Global Market Access Lead, Narcolepsy (Director Level)

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms of Use. I further attest that all information I submit in my employment application is true to the best of my knowledge.

Job Description

Are you looking for a patient-focused, innovation-driven company that will inspire you and empower you to shine? Join us as the Global Market Access Lead, Narcolepsy.

This position sits in the The Global Product & Launch Strategy (GPLS) group, which is part of our Global Portfolio Division comprised of approximately 10,000 employees spanning over 70 countries.  Our GPLS organization is responsible for our global product strategy organization focused on fueling the growth of Takeda through our inline portfolio strategy and focus on the life cycle management, as well as on launching the future by focusing on our rich pipeline. Our key goal is to prepare to commercialize our unprecedented pipeline that includes best-in-class or in first-class therapies, many of which have complex or under-developed markets or therapy areas.

Objectives:

• Deliver Market Access strategy and tactics for TAK861/ Orexin within Neuroscience portfolio to ensure successful pricing negotiations and reimbursement in countries.

• Provide a single point of contact for all market access needs and activities for Orexin within Neuroscience Franchise.

• Provide input into clinical development programs for orexins programs as needed to ensure the right evidence is collected to support reimbursement and pricing negotiations.

• Understand the access and payer evidence needs and propose strategic, implementable solutions to support reimbursement, sustainable value and patient access.

Accountabilities:

• Be an active member of a cross-functional Global Pricing and Access team within selected Global Product Teams that develop and deliver an integrated patient access and value strategy for all early assets and BD products based on a deep understanding of the science and disease, patient and care giver needs, and the evolving payer landscape and evidence requirements.

• Partner with major countries and Global Market Insights teams to ensure that the market access and value strategy contributes to the definition of the asset strategy of each relevant pipeline product so that at launch the product delivers the value proposition most relevant to payers and is supported by a robust global value story, compelling evidence package, and pricing strategy to maximize both patient access and the life-time value of the product.

• Work very closely with GHE & Pricing colleagues to ensure “one Team one voice” within the entire organization. Represent GPA voice and position in the various key meetings leverage and ensure  right representation of GPA key expertise (GHE Pricing) whenever relevant.

• Evaluate and influence evidence generation plans by synthesizing payer/HTA insights.  Anticipate the outcomes of key HTA body assessments to determine the implications for value positioning and evidence requirements. 

• Support GPA preparation to all key governance meetings (PRC, CLC).

• Develop the global, integrated Market Access Plan (TVP in collaboration with GHE, Evidence, Strategic Pricing, Stakeholder Engagement and LOC Implementation) and implement Access deliverables to achieve successful reimbursement and pricing for Takeda’s assigned Therapeutic Area products.

• Explore and develop innovative access frameworks that consider and anticipate the evolving health care environment to create win-win-win situations for patients, payers and Takeda.

• Lead horizon scanning and in-depth understanding of payer